PI3K-C2β limits mTORC1 signaling and angiogenic growth
Piotr Kobialka(Goethe University Frankfurt), Mariona Graupera(Josep Carreras Leukaemia Research Institute), Joaquím Grego‐Bessa(Josep Carreras Leukaemia Research Institute), Jorge Andrade(Max Planck Institute for Heart and Lung Research), Ana Angulo‐Urarte(Institut d'Investigació Biomédica de Bellvitge), Alejo Efeyan(Spanish National Cancer Research Centre), Bart Vanhaesebroeck(Ludwig Cancer Research), Laia Muixí(Institut d'Investigació Biomédica de Bellvitge), Michael Potente(Max Delbrück Center), Pilar Villacampa(Josep Carreras Leukaemia Research Institute), Nerea Deleyto-Seldas(Spanish National Cancer Research Centre), Hielke van Splunder(Josep Carreras Leukaemia Research Institute), Margalida Munar-Gelabert(Josep Carreras Leukaemia Research Institute), Jose A. Dengra(Josep Carreras Leukaemia Research Institute), Judith Llena(Josep Carreras Leukaemia Research Institute), Alba Albinyà-Pedrós(Josep Carreras Leukaemia Research Institute), Sandra D. Castillo(Sant Joan de Déu Research Foundation)
Cited by 10
Related Papers
mTOR: from growth signal integration to cancer, diabetes and ageing
|Nature Reviews Molecular Cell Biology|2010|4k
mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H <sup>+</sup> -ATPase
|Science|2011|1.6k
Senescence in premalignant tumours
|Nature|2005|1.5k
Nutrient-sensing mechanisms and pathways
|Nature|2015|1.1k
SIRT1 controls endothelial angiogenic functions during vascular growth
|Genes & Development|2007|602